FI932445L - PHARMACEUTICAL ASSOCIATIONS - Google Patents

PHARMACEUTICAL ASSOCIATIONS Download PDF

Info

Publication number: FI932445L
Authority: FI; Finland
Prior art keywords: pharmaceutical associations; associations; pharmaceutical
Prior art date: 1992-05-29

Application number

FI932445A

Other languages

Finnish (fi)

Other versions

FI932445A0 (en

FI101538B1 (en

FI101538B (en

Inventor

John Fairhurst

Terrence Michael Hotten

David Edward Tupper

Original Assignee

Lilly Industries Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-05-29

Filing date

1993-05-28

Publication date

1993-11-30

1992-05-29 Priority claimed from GB929211379A external-priority patent/GB9211379D0/en

1993-04-30 Priority claimed from GB939309025A external-priority patent/GB9309025D0/en

1993-05-28 Application filed by Lilly Industries Ltd filed Critical Lilly Industries Ltd

1993-05-28 Publication of FI932445A0 publication Critical patent/FI932445A0/en

1993-11-30 Publication of FI932445L publication Critical patent/FI932445L/en

1998-07-15 Application granted granted Critical

1998-07-15 Publication of FI101538B1 publication Critical patent/FI101538B1/en

1998-07-15 Publication of FI101538B publication Critical patent/FI101538B/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Medicinal Chemistry (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Hospice & Palliative Care (AREA)
Anesthesiology (AREA)
Addiction (AREA)
Otolaryngology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

FI932445A 1992-05-29 1993-05-28 Process for the preparation of novel therapeutically useful 2-methyl-4- (4-methyl-1-piperazinyl) -10H-thieno 2,3-b | £ 1,5 | benzodiazepine derivatives FI101538B (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB929211379A GB9211379D0 (en)	1992-05-29	1992-05-29	Pharmaceutical compounds
GB939309025A GB9309025D0 (en)	1993-04-30	1993-04-30	Pharmaceutical compounds

Publications (4)

Publication Number	Publication Date
FI932445A0 FI932445A0 (en)	1993-05-28
FI932445L true FI932445L (en)	1993-11-30
FI101538B1 FI101538B1 (en)	1998-07-15
FI101538B FI101538B (en)	1998-07-15

Family

ID=26300951

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI932445A FI101538B (en)	1992-05-29	1993-05-28	Process for the preparation of novel therapeutically useful 2-methyl-4- (4-methyl-1-piperazinyl) -10H-thieno 2,3-b \| £ 1,5 \| benzodiazepine derivatives

Country Status (21)

Country	Link
EP (1)	EP0582368B1 (en)
JP (1)	JP3219541B2 (en)
CN (1)	CN1043994C (en)
AT (1)	ATE198891T1 (en)
AU (1)	AU668159B2 (en)
CA (1)	CA2097016A1 (en)
CZ (1)	CZ282783B6 (en)
DE (1)	DE69329887T2 (en)
DK (1)	DK0582368T3 (en)
ES (1)	ES2153373T3 (en)
FI (1)	FI101538B (en)
GR (1)	GR3035587T3 (en)
HU (1)	HU218278B (en)
IL (1)	IL105827A (en)
MX (1)	MX9303124A (en)
MY (1)	MY109943A (en)
NO (1)	NO305125B1 (en)
NZ (1)	NZ247703A (en)
PT (1)	PT582368E (en)
RU (1)	RU2125574C1 (en)
TW (1)	TW268005B (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5457101A (en) *	1994-06-03	1995-10-10	Eli Lilly And Company	Thieno[1,5]benzoidiazepine use
US5574028A (en) *	1994-10-31	1996-11-12	Eli Lilly And Company	Method for treating anxiety
CR5278A (en) *	1995-03-24	1996-07-04	Lilly Co Eli	ORAL FORMULATION OF 2-METHYL-THENO-BENZODIACEPINE
EG24221A (en) *	1995-03-24	2008-11-10	Lilly Co Eli	Process for preparing olanzapine
EG23659A (en) *	1995-03-24	2007-03-26	Lilly Co Eli	Process and crystal forms of methyl-thieno-benzodiazepine
US5891461A (en) *	1995-09-14	1999-04-06	Cygnus, Inc.	Transdermal administration of olanzapine
US6258807B1 (en) *	1996-03-25	2001-07-10	Eli Lilly And Company	Method for treating pain
JP2001508759A (en) *	1996-03-25	2001-07-03	イーライ・リリー・アンド・カンパニー	Migraine treatment
UA48219C2 (en) *	1996-03-25	2002-08-15	Елі Ліллі Енд Компані	Pain-relieving composition (variants) and method for relieving pain
ZA978515B (en) *	1996-09-23	1999-03-23	Lilly Co Eli	Intermediates and process for preparing olanzapine
BR9711541A (en) *	1996-09-23	1999-08-24	Lilly Co Eli	Olanzapine dihydrate
WO1998013027A1 (en) *	1996-09-24	1998-04-02	Eli Lilly And Company	Coated particle formulation
US9494607B2 (en)	2012-08-21	2016-11-15	Janssen Pharmaceutica Nv	Antibodies to aripiprazole and use thereof
CA2882557C (en)	2012-08-21	2020-10-27	Ortho-Clinical Diagnostics, Inc.	Haptens of quetiapine for use in immunoassays
US9751953B2 (en)	2012-08-21	2017-09-05	Janssen Pharmaceutica Nv	Antibodies to risperidone haptens and use thereof
US9611332B2 (en)	2012-08-21	2017-04-04	Janssen Pharmaceutica Nv	Antibodies to aripiprazole haptens and use thereof
JP6171014B2 (en) *	2012-08-21	2017-07-26	ヤンセンファーマシューティカエヌ．ベー．	Olanzapine hapten
AU2013305904B2 (en)	2012-08-21	2017-08-17	Saladax Biomedical Inc.	Antibodies to quetiapine haptens and use thereof
CN104736566A (en)	2012-08-21	2015-06-24	奥索临床诊断有限公司	Antibodies to paliperidone haptens and use thereof
ES2904838T3 (en)	2012-08-21	2022-04-06	Janssen Pharmaceutica Nv	Haptens of risperidone and paliperidone
PL2888234T3 (en)	2012-08-21	2018-07-31	Janssen Pharmaceutica Nv	Haptens of aripiprazole and their use in immunoassays
EP2888277A4 (en)	2012-08-21	2016-05-18	Ortho Clinical Diagnostics Inc	Antibodies to paliperidone and use thereof
CA2882555C (en)	2012-08-21	2018-11-06	Janssen Pharmaceutica Nv	Haptens of paliperidone
WO2014031648A2 (en)	2012-08-21	2014-02-27	Ortho-Clinical Diagnostics, Inc	Antibodies to risperidone and use thereof
PT2888590T (en)	2012-08-21	2020-09-11	Janssen Pharmaceutica Nv	Antibodies to olanzapine and use thereof
US9410972B2 (en)	2012-08-21	2016-08-09	Janssen Pharmaceutica Nv	Antibodies to quetiapine and use thereof
ES2733963T3 (en)	2012-08-21	2019-12-03	Janssen Pharmaceutica Nv	Antibodies against olanzapine haptens and their use
EP3390455A1 (en)	2015-12-17	2018-10-24	Janssen Pharmaceutica NV	Antibodies to quetiapine and use thereof
JP6949025B2 (en)	2015-12-17	2021-10-13	ヤンセンファーマシューティカエヌ．ベー．	Antibodies to risperidone and its use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SU629879A3 (en) *	1974-11-26	1978-10-25	Лилли Индастриз Лимитед, (Фирма)	Method of obtaining thieno(1,5)-benzodiazepines or salts thereof
DK416476A (en) *	1975-09-24	1977-03-25	Sandoz Ag	PROCEDURE FOR THE PREPARATION OF DIAZEPINE DERIVATIVES
GB9009229D0 (en) *	1990-04-25	1990-06-20	Lilly Industries Ltd	Pharmaceutical compounds

1993
- 1993-05-26 NO NO931917A patent/NO305125B1/en not_active IP Right Cessation
- 1993-05-26 ES ES93304102T patent/ES2153373T3/en not_active Expired - Lifetime
- 1993-05-26 TW TW082104161A patent/TW268005B/zh active
- 1993-05-26 EP EP93304102A patent/EP0582368B1/en not_active Expired - Lifetime
- 1993-05-26 PT PT93304102T patent/PT582368E/en unknown
- 1993-05-26 NZ NZ247703A patent/NZ247703A/en unknown
- 1993-05-26 AT AT93304102T patent/ATE198891T1/en not_active IP Right Cessation
- 1993-05-26 DE DE69329887T patent/DE69329887T2/en not_active Expired - Fee Related
- 1993-05-26 DK DK93304102T patent/DK0582368T3/en active
- 1993-05-26 CA CA002097016A patent/CA2097016A1/en not_active Abandoned
- 1993-05-26 AU AU39807/93A patent/AU668159B2/en not_active Ceased
- 1993-05-27 MX MX9303124A patent/MX9303124A/en not_active IP Right Cessation
- 1993-05-28 MY MYPI93001036A patent/MY109943A/en unknown
- 1993-05-28 IL IL10582793A patent/IL105827A/en not_active IP Right Cessation
- 1993-05-28 CZ CZ931024A patent/CZ282783B6/en not_active IP Right Cessation
- 1993-05-28 FI FI932445A patent/FI101538B/en active
- 1993-05-28 CN CN93108212A patent/CN1043994C/en not_active Expired - Fee Related
- 1993-05-28 HU HU9301579A patent/HU218278B/en not_active IP Right Cessation
- 1993-05-28 JP JP12642993A patent/JP3219541B2/en not_active Expired - Fee Related
- 1993-05-28 RU RU93005057A patent/RU2125574C1/en active
2001
- 2001-03-15 GR GR20010400431T patent/GR3035587T3/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
DE69329887D1 (en)	2001-03-01
NO305125B1 (en)	1999-04-06
MY109943A (en)	1997-10-31
JP3219541B2 (en)	2001-10-15
DK0582368T3 (en)	2001-02-05
EP0582368B1 (en)	2001-01-24
IL105827A0 (en)	1993-09-22
CZ102493A3 (en)	1993-12-15
FI932445A0 (en)	1993-05-28
CN1085903A (en)	1994-04-27
FI101538B1 (en)	1998-07-15
NO931917L (en)	1993-11-30
GR3035587T3 (en)	2001-06-29
HUT66180A (en)	1994-09-28
NO931917D0 (en)	1993-05-26
IL105827A (en)	1997-02-18
HU9301579D0 (en)	1993-09-28
RU2125574C1 (en)	1999-01-27
ES2153373T3 (en)	2001-03-01
AU668159B2 (en)	1996-04-26
AU3980793A (en)	1993-12-02
MX9303124A (en)	1993-11-01
JPH0687862A (en)	1994-03-29
HU218278B (en)	2000-07-28
FI101538B (en)	1998-07-15
ATE198891T1 (en)	2001-02-15
CN1043994C (en)	1999-07-07
DE69329887T2 (en)	2001-05-23
PT582368E (en)	2001-05-31
CZ282783B6 (en)	1997-10-15
EP0582368A1 (en)	1994-02-09
NZ247703A (en)	1995-07-26
CA2097016A1 (en)	1993-11-30
TW268005B (en)	1996-01-11

Publication	Publication Date	Title
FI932445L (en)	1993-11-30	PHARMACEUTICAL ASSOCIATIONS
NO942923L (en)	1994-08-05	drugs
FI930882A (en)	1993-08-29	PHARMACEUTICAL FORM
FI911986L (en)	1991-10-26	PHARMACEUTICAL ASSOCIATIONS.
FI951098L (en)	1995-03-09	Pharmaceutical packaging
FI924340L (en)	1992-09-28	PHARMACEUTICAL PREPARATIONS
NO954146D0 (en)	1995-10-18	Coated pharmaceutical preparations
BR1100824A (en)	1999-08-31	Pharmaceutical composition and composition
FI921060L (en)	1992-09-15	PHARMACEUTICAL AEROSOL FORMULERINGAR
NO923127L (en)	1993-02-15	PHARMACEUTICAL COMBINATION FORM
NO923859D0 (en)	1992-10-02	DRUG
NO931831D0 (en)	1993-05-19	PHARMACEUTICAL MIXTURES
FI935584L (en)	1995-06-14	Pharmaceutical granulate
FI935065L (en)	1994-05-19	Pharmaceutical associations
FI931251L (en)	1993-09-25	PHARMACEUTICAL ASSOCIATIONS
FI955605A0 (en)	1995-11-21	Aryling drug
DK86492D0 (en)	1992-06-30	PHARMACEUTICAL PRODUCT
FI921877L (en)	1992-10-30	PHARMACEUTICAL ASSOCIATIONS
NO961589D0 (en)	1996-04-19	Pharmaceutical mixtures
FI930128L (en)	1993-07-15	DOSAGE LIST
FI934387A0 (en)	1993-10-06	3-SUBSTITUTES 2-OXI-INDOL-1-CARBOXIAMIDE PHARMACEUTICAL COMPOSITION
FI923869L (en)	1993-03-06	PHARMACEUTICAL SUBSTANCE
FI934317A0 (en)	1993-10-01	PHARMACEUTICAL SAMMANSAETTNINGAR, VILKA INNEHAOLLER EJ-JONISKA YTAKTIVA AEMNEN
ATA83492A (en)	1994-05-15	DESTRUCTION
NO920039D0 (en)	1992-01-02	PHARMACEUTICAL PREPARATIONS